Thompson Rahsaan
Insider CIK 1788524 · ZVRA Chief Legal & Compliance · GRTS See Remarks · LYEL Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2026-08-14 | 2026-08-17 | 42,666 | $11.13 | $474.9K | 37,569 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2026-08-14 | 2026-08-17 | 42,666 | $11.13 | $474.8K | 37,569 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2026-06-22 | 2026-06-23 | 34,557 | $12.68 | $438.2K | 80,235 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise deriv | 2026-06-21 | 2026-06-23 | 66,667 | — | $0 | 66,667 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise | 2026-06-21 | 2026-06-23 | 66,667 | — | $0 | 114,792 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2026-05-11 | 2026-05-13 | 1,794 | $11.30 | $20.3K | 48,125 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise deriv | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 22,667 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 53,999 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2026-01-30 | 2026-02-02 | 4,080 | $8.83 | $36.0K | 49,919 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2026-01-29 | 2026-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2026-01-29 | 2026-02-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | S Sale | 2025-06-26 | 2025-06-30 | 24,000 | $9.21 | $221.0K | 42,666 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise deriv | 2025-06-21 | 2025-06-24 | 66,666 | — | $0 | 133,334 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | M Exercise | 2025-06-21 | 2025-06-24 | 66,666 | — | $0 | 66,666 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2025-01-30 | 2025-02-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2025-01-30 | 2025-02-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2024-06-21 | 2024-06-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2023-02-24 | 2023-02-28 | 245,000 | — | $0 | 245,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | A Award deriv | 2022-10-10 | 2022-10-12 | 715,000 | — | $0 | 715,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2022-01-31 | 2022-04-20 | 115,440 | — | $0 | 115,440 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2022-01-31 | 2022-04-20 | 19,240 | — | $0 | 58,698 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2021-03-08 | 2021-03-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award | 2021-01-07 | 2021-11-19 | 25,500 | — | $0 | 29,487 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2020-05-13 | 2020-05-15 | 85,000 | — | $0 | 85,000 | SEC↗ |